Acro Biomedical Co. Ltd. (ACBM)
0.026
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Acro Biomedical Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 17.78% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 25.63% |
| December 31, 2021 | 25.08% |
| September 30, 2021 | |
| June 30, 2021 | 16.00% |
| March 31, 2021 | 29.65% |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | 23.17% |
| December 31, 2019 | 6.25% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| September 30, 2018 | 10.50% |
| June 30, 2018 | 10.91% |
| March 31, 2018 | 10.00% |
| December 31, 2017 | 10.00% |
| September 30, 2017 | 10.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Stella Diagnostics, Inc. | -14.09% |
| DataMeds AI, Inc. | -9.80% |
| Interpace Biosciences, Inc. | 61.91% |
| Medical Marijuana, Inc. | 83.04% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -886.4% |
| Return on Net Operating Assets | -1.20K% |